In furtherance to intimation dated May 26, 2025 with respect to the Scheme of Amalgamation of Sesa Care (‘Transferor Company’) with and into Dabur India (‘Company’ or ‘Transferee Company’) and their respective shareholders and creditors under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 read with rules made thereunder (‘Scheme’), Dabur India has informed that the Company has received observation letter with 'no adverse observations' from BSE on December 04, 2025. A copy of the said letter is enclosed. The Scheme remains subject to various statutory and regulatory approvals and of the respective shareholders and creditors of the companies involved in the Scheme, as may be required. The observation letter received from BSE is also made available on the website of the Company at www.dabur.com.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Hindustan Unilever | 2244.30 |
| Godrej Consumer Prod | 1104.65 |
| Dabur India | 449.00 |
| Colgate Palmol. (I) | 2081.45 |
| P&G Hygiene | 10142.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: